Duopharma Biotech’s buying momentum may have returned after it rose above the 21-day SMA line. Yesterday’s white candle can be regarded as a continuation of the rebound that started off 15 Mar’s “Hammer” pattern. A bullish bias may emerge above the MYR1.13 level, with an exit set below the MYR1.08 threshold. Towards the upside, the immediate resistance is at MYR1.17. This is followed by the MYR1.20 level.

Source: RHB Securities Research - 20 Mar 2019